# Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy

> **NCT00367562** · PHASE4 · COMPLETED · sponsor: **Hospital Britanico** · enrollment: 20 (—)

## Conditions studied

- IGA Nephropathy

## Interventions

- **DRUG:** ENALAPRIL VALSARTAN METHYLPREDNISONE

## Key facts

- **NCT ID:** NCT00367562
- **Lead sponsor:** Hospital Britanico
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-01
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 20 (—)
- **Last updated:** 2006-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00367562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00367562, "Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00367562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*